Deseret Mutual Benefit Administrators’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Deseret Mutual Benefit Administrators's BMY Position: Q2 2026 in Review
Deseret Mutual Benefit Administrators reduced its Bristol-Myers Squibb (BMY) stake by 16% in Q2 2026, selling an estimated $127K and leaving 11,752 shares worth $677K. The position accounts for 0.22% of the portfolio, ranked #78.
Deseret Mutual Benefit Administrators first reported a position in BMY in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.94M in Q2 2022. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Deseret Mutual Benefit Administrators held 11,752 shares of Bristol-Myers Squibb worth $677K as of Q2 2026.
- Deseret Mutual Benefit Administrators sold 2,216 Bristol-Myers Squibb shares in Q2 2026, an estimated $127K.
- Bristol-Myers Squibb made up 0.22% of Deseret Mutual Benefit Administrators's portfolio in Q2 2026, its #78 holding.
- Deseret Mutual Benefit Administrators first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 21 quarters since.
- Deseret Mutual Benefit Administrators's Bristol-Myers Squibb position peaked at $1.94M in Q2 2022.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Deseret Mutual Benefit Administrators's 13F filing for Q2 2026, filed 14 Aug 2026.